- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Exhibit 12.1
Adverum Biotechnologies, Inc.
Deficiency of earnings
March 31, 2018
| Three Months |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
| Ended March 31, |
|
| Year Ended December 31, |
| ||||||||||||||
|
| 2018 |
|
| 2017 |
|
| 2016 |
|
| 2015 |
|
| 2014 |
| |||||
|
| (In thousands) |
| |||||||||||||||||
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on indebtedness |
| $ | 7 |
|
| $ | 27 |
|
| $ | 25 |
|
| $ | 14 |
|
| $ | 0 |
|
Interest expense on portion of rent expense representative of interest |
| $ | 32 |
|
|
| 126 |
|
|
| 122 |
|
|
| 92 |
|
|
| 18 |
|
Total fixed charges |
| $ | 38 |
|
| $ | 152 |
|
| $ | 147 |
|
| $ | 106 |
|
| $ | 18 |
|
Preferred stock deemed dividend |
| $ | 0 |
|
| $ | 0 |
|
| $ | 0 |
|
| $ | 0 |
|
| $ | 3,230 |
|
Total fixed charges and preferred dividend |
| $ | 38 |
|
| $ | 152 |
|
| $ | 147 |
|
| $ | 106 |
|
| $ | 3,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| (17,200 | ) |
|
| (56,147 | ) |
|
| (114,522 | ) |
|
| (47,453 | ) |
|
| (25,404 | ) |
Fixed charges per above |
|
| 38 |
|
|
| 152 |
|
|
| 147 |
|
|
| 106 |
|
|
| 18 |
|
Total earnings (loss) |
|
| (17,162 | ) |
|
| (55,995 | ) |
|
| (114,375 | ) |
|
| (47,347 | ) |
|
| (25,386 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratio of earnings to fixed charges |
| N/A |
|
| N/A |
|
| N/A |
|
| N/A |
|
| N/A |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deficiency of earnings available to cover fixed charges |
|
| (17,200 | ) |
|
| (56,147 | ) |
|
| (114,522 | ) |
|
| (47,453 | ) |
|
| (28,634 | ) |